Main Banner Desktop
royalpharm

Hangzhou Royall Import & Export Co., Ltd.

Unverified company Unverified company

lenvatinib(CAS No.417716-92-8)


Unit Price:

Not informed

FOB Price:

Not informed

Minimum Order Quantity:

Not informed

Type of Payment:

Not informed

Preferred Port:

Not informed

Reference:

Not informed


Description

Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.

  • API
  • antitumor&amp
  • anti-cancer

Production Capacity:

Not informed

Delivery Timeframe:

Not informed

Incoterms:

Not informed

Packaging Details:

Not informed


More about
Hangzhou Royall Import & Export Co., Ltd.

icone de usuario

Not informed

sales icon

Not informed

icone de exportar

Not informed

Not informed

Year

Established


Business type
  • Industry / Manufacturer
  • Importer / Trading Company

Keywords
  • Active Pharmaceutical Ingredients (API)
  • Pharmaceutical Intermediates
  • Contrast Agent Supplier
  • Iohexol Manufacturer
  • Custom Synthesis Services
  • Peptide API
  • Pharmaceutical Machinery
  • GMP Validation Services
  • Contract Manufacturing (Pharma)
  • Distilled Water Machine
  • Ver Mais

Contact and location
  • icone de usuario Mory ********
  • icone de telefone +86 1********
  • map-marker 杭州 / | China

Make your Request!

Make your Request!

Start conversation
logo-Whatsapp

Hello 👋!
Can we help you?

Fill in your name and phone number 😁

Start conversation Start conversation